Form 4: Dyne Therapeutics SVP Richard Scalzo Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Richard Scalzo, SVP, Head of Finance & Admin. at Dyne Therapeutics, sold 917 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 5, 2025, Richard William Scalzo, SVP, Head of Finance & Admin. at Dyne Therapeutics, sold 917 shares of Dyne Therapeutics (DYN) common stock.
- The sale was executed at a weighted average price of $11.83 per share, with individual transactions ranging from $11.73 to $11.94.
- The sale was to cover tax withholding obligations related to the vesting of restricted stock units (RSUs) granted on December 4, 2024.
- Following the transaction, Scalzo directly owns 123,673 shares of Dyne Therapeutics, which includes 112,036 unvested RSUs.
Sentiment
Score: 6
Explanation: The document reports a routine transaction (stock sale for tax obligations). It doesn't indicate any significant positive or negative sentiment regarding the company's performance or future prospects.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally viewed as routine transactions.
Key Dates
| Date | Description |
|---|---|
| 12/04/2024 | Date of restricted stock units grant |
| 03/05/2025 | Date of stock sale |
| 03/07/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.